Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHINX: Pharmacogenetics-guided Isoniazid Dosing in HIV-TB
NCT05124678Phase 2Unknown
- Sponsor
- Makerere University
- Start
- Dec 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isoniazid in Tuberculosis (TB), sponsored by Makerere University. Status: unknown.
02
Drugs
isoniazid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05124678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05124678.